Effect of time of umbilical cord clamping on serum bilirubin level among full-term newborns.

Not Applicable

• Conditions: Pregnancy and Childbirth; Paediatrics

• Registration Number: PACTR202010878847651

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2019-05-02
• Results First Posted: 2020-09-16
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 155

Inclusion Criteria

A live newborn with a gestational age of 37-42 weeks diagnosed with the first day of last menstrual period (LMP) or ultrasound.
A live newborn who has no gross complications related to pregnancy and delivery (including mal-presentation, fetal distress, and congenital malformations).
A live newborn with whom the mother agreed and give informed consent.
A live newborn with whom body weight is above 2500gm and below 4000gm at birth.
A live newborn with whom first and 5th minute Apgar score = 7.

Exclusion Criteria

A mother with rhesus negative blood group or any medical or obstetric complications (hepatitis, HIV/AIDS, hypertensive disorders of pregnancy, diabetes and severe anemia).
A newborn with known congenital malformation during pregnancy or delivery.
Confirmed multiple pregnancy and mal-presentation.
Neonate that require immediate resuscitation.
Newborns with a body weight of above 4100gm.
Newborns with their gestational age at birth is >42 weeks.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Serum bilirubin level of the newborn and related hyperbilirubinemia that requires phototherapy.

Secondary Outcome Measures

Name	Time	Method
The proportion of newborns that required a phototherapy treatment.